Search results
Results From The WOW.Com Content Network
Genentech was founded by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. After a meeting in 1976, the two decided to start a biotechnology company, Genentech. Although the two confidently assert that it was the first biotech company, others clearly came before, including Cetus Corporation which was founded in 1971.
Rank Drug Main indication Trade name 2018 sales (million USD) 2017 sales (million USD) 1 adalimumab: rheumatoid arthritis: Humira 19 936 18427 3 apixaban
Roche acquired Syntex in 1994, and Chugai Pharmaceuticals in 2002. Oseltamivir an antiviral drug used to combat influenza. Roche is the only drug company authorized to manufacture the drug, which was discovered by Gilead Sciences. Roche purchased the rights to the drug in 1996, and in 2005, settled a royalty dispute, agreeing to pay Gilead ...
Genentech previously said the use of the drug in the indication accounts for a fraction of its overall revenue. ... Roche, however, decided to terminate the deal with Blueprint earlier this year ...
Roche will finally buy Genentech (DNA) after months of fighting over a price for the acquisition. According to The Wall Street Journal (subscription required), "Swiss drug maker Roche Holding AG ...
Roche agreed to take over obesity drug developer Carmot Therapeutics for $2.7 billion, joining a list global contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk ...
Risdiplam was approved by the US Food and Drug Administration (FDA) in August 2020, for the treatment of adults and children two months of age or older. [6] [11] Developed by Roche in Basel, Switzerland, [12] in association with PTC Therapeutics and the SMA Foundation, [9] [11] it is marketed in the US by Genentech, [6] a subsidiary of Roche. [11]
Formula. C6670H10317N1745O2087S40. Molar mass. 149 627.43 g·mol −1. Polatuzumab vedotin, sold under the brand name Polivy, is a CD79b -directed antibody-drug conjugate medication used for the treatment of diffuse large B-cell lymphoma ( cancer ). [6] It was developed by the Genentech subsidiary of Roche. [8]